Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.
Einband grossThe Evolution of Immunotherapy Against Tumors
ISBN/GTIN

The Evolution of Immunotherapy Against Tumors

E-BookEPUBDRM AdobeE-Book
180 Seiten
Englisch
Elsevier Science & Techn.erschienen am20.09.2024
The Evolution of Immunotherapy Against Tumors: An Historical Approach summarizes the literature concerning the development of the theory of immune surveillance against tumors. It discusses the evidence for and against this theory, along with the concept of immunoediting. Finally, current approaches in anti-tumor immunotherapy will be analyzed. The immune system plays a major role in the surveillance against tumors. To avoid attack from the immune system, tumor cells develop different strategies to escape immune surveillance. Evidence of immune surveillance comes from both animal models and clinical observations. Mice with a wide variety of immunodeficiencies have a high rate of tumor incidence and are more susceptible to transplanted or chemical carcinogen-induced tumors. Immunosuppressed patients have a high incidence of tumors. However, many patients develop cancer even in the presence of an apparently normal immune system. This indicates that tumor cells can escape immune surveillance.
Covers the experimental approaches to investigate immunotherapy against tumors
Provides a comprehensive overview of the pharmacological tools in this field
Serves as a reference book to researchers in the respective fields and related disciplines
mehr
Verfügbare Formate
TaschenbuchKartoniert, Paperback
EUR169,50
E-BookEPUBDRM AdobeE-Book
EUR162,00

Produkt

KlappentextThe Evolution of Immunotherapy Against Tumors: An Historical Approach summarizes the literature concerning the development of the theory of immune surveillance against tumors. It discusses the evidence for and against this theory, along with the concept of immunoediting. Finally, current approaches in anti-tumor immunotherapy will be analyzed. The immune system plays a major role in the surveillance against tumors. To avoid attack from the immune system, tumor cells develop different strategies to escape immune surveillance. Evidence of immune surveillance comes from both animal models and clinical observations. Mice with a wide variety of immunodeficiencies have a high rate of tumor incidence and are more susceptible to transplanted or chemical carcinogen-induced tumors. Immunosuppressed patients have a high incidence of tumors. However, many patients develop cancer even in the presence of an apparently normal immune system. This indicates that tumor cells can escape immune surveillance.
Covers the experimental approaches to investigate immunotherapy against tumors
Provides a comprehensive overview of the pharmacological tools in this field
Serves as a reference book to researchers in the respective fields and related disciplines
Details
Weitere ISBN/GTIN9780443217999
ProduktartE-Book
EinbandartE-Book
FormatEPUB
Format HinweisDRM Adobe
Erscheinungsjahr2024
Erscheinungsdatum20.09.2024
Seiten180 Seiten
SpracheEnglisch
Dateigrösse24048 Kbytes
Artikel-Nr.17486487
Rubriken
Genre9200

Inhalt/Kritik

Inhaltsverzeichnis
Immunosurveillance against tumors Immunoediting Basic immunotherapy with IL-2 Adoptive T cell therapy DNA vaccines Dendritic cell (DC) vaccines Antibody therapy Co-applying anti-angiogenic and immune checkpoints inhibitors Conclusionsmehr

Autor

Domenico Ribatti was awarded his M.D. degree in October 1981, with full marks. In 1983, D.R. joined the Medical School as Assistant at the Institute of Human Anatomy, University of Bari. In 1984, he took the specialization in Allergology. In 1989, he spent one year in Geneva, working at the Department of Morphology (Prof. R. Montesano). In 2008, he received the honoris causa degree in Medicine and Pharmacy form the University of Timisoara (Romania). D.R. is author of 866 publications as reported in PUBmed and contributed to 50 chapters to books. Overall, his papers have been cited 51153 times.

He has published many books with both Elsevier and Springe